SOFVASC HCT 10/160/12.5MG TAB

SOFVASC HCT is a triple-combination antihypertensive tablet containing Amlodipine 10mg, Valsartan 160mg, and Hydrochlorothiazide 12.5mg. This formulation is designed for patients requiring multi-drug therapy to manage high blood pressure effectively. Amlodipine works as a calcium channel blocker to relax blood vessels, Valsartan is an angiotensin II receptor antagonist that reduces vasoconstriction, and Hydrochlorothiazide is a thiazide diuretic that helps reduce fluid volume. Together, these three active ingredients provide comprehensive blood pressure control through complementary mechanisms of action. SOFVASC HCT is indicated for hypertensive patients who have not achieved adequate blood pressure control with dual therapy or who require simplified dosing with a single tablet. Each tablet delivers consistent, reliable dosing for improved patient compliance and better cardiovascular outcomes.